Use of innovative injectable devices has brought patient healthcare away from the hospital and into the home setting. This has a profound positive influence on patient adherence to treatment regimen, improving quality of life of the patients. This article thus focuses on some important issues that determine patient compliance with new and improved injectable drug delivery devices. It is expected that globally, the injectable drug delivery device market will increase from $11.6 billion in 2013 to $17.5 billion in 2018.
Technological advancements and increased demand for self-injectable devices are the main contributing factors for this market growth. Nevertheless, in spite of this rapid growth there are factors which limit the usage of self-injectable drugs. Two issues that limit the self-administration of injectable drugs: High volume : Patients often need to be injected with biologic…
